Claritas Rx Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
110

- Latest Deal Type
-
Series A3
- Latest Deal Amount
-
$13.6M
- Investors
-
2
Claritas Rx General Information
Description
Developer of a data integration and analytics platform designed to help improve the patient experience beyond the clinical trial. The company's platform automates commercial and clinical data and helps in finding variables impacting patient access and duration of therapy along with patient behavioral and performance trends, enabling the biopharmaceutical industry to generate actionable business insights into commercial strategies and operational improvements.
Contact Information
Website
www.claritasrx.comCorporate Office
- 611 Gateway Boulevard
- Suite 201
- South San Francisco, CA 94080
- United States
Corporate Office
- 611 Gateway Boulevard
- Suite 201
- South San Francisco, CA 94080
- United States
Claritas Rx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series A3) | 19-Feb-2021 | $13.6M | Completed | Generating Revenue | ||
2. Seed Round | 27-Jul-2020 | Completed | Generating Revenue | |||
1. Debt - PPP | 16-Apr-2020 | $898K | Completed | Generating Revenue |
Claritas Rx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-3 | ||||||||
Series A-2 | ||||||||
Series A-1 | 1,997,393 | $0.000010 | 6% | $6.01 | $6.01 | 1x | $6.01 | 27.5% |
Series Seed | 1,025,597 | $0.000010 | 6% | $3.07 | $3.07 | 1x | $3.07 | 14.12% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Claritas Rx Comparisons
Industry
Financing
Details
Claritas Rx Competitors (8)
One of Claritas Rx’s 8 competitors is Inovalon Holdings, a Private Equity-Backed company based in Bowie, MD.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Inovalon Holdings | Private Equity-Backed | Bowie, MD | ||||
Health Gorilla | Venture Capital-Backed | Mountain View, CA | ||||
RxDataScience | Formerly Angel backed | Morrisville, NC | ||||
PrimeRx | Private Equity-Backed | New York, NY | ||||
Clarity Software Solutions | Private Equity-Backed | Madison, CT |
Claritas Rx Signals
Claritas Rx Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Questa Capital | Venture Capital | Minority | ||
Kiplin Capital | Venture Capital | Minority |
Claritas Rx FAQs
-
When was Claritas Rx founded?
Claritas Rx was founded in 2011.
-
Where is Claritas Rx headquartered?
Claritas Rx is headquartered in South San Francisco, CA.
-
What is the size of Claritas Rx?
Claritas Rx has 110 total employees.
-
What industry is Claritas Rx in?
Claritas Rx’s primary industry is Enterprise Systems (Healthcare).
-
Is Claritas Rx a private or public company?
Claritas Rx is a Private company.
-
What is the current valuation of Claritas Rx?
The current valuation of Claritas Rx is
. -
What is Claritas Rx’s current revenue?
The current revenue for Claritas Rx is
. -
How much funding has Claritas Rx raised over time?
Claritas Rx has raised $16.5M.
-
Who are Claritas Rx’s investors?
Questa Capital and Kiplin Capital have invested in Claritas Rx.
-
Who are Claritas Rx’s competitors?
Inovalon Holdings, Health Gorilla, RxDataScience, PrimeRx, and Clarity Software Solutions are some of the 8 competitors of Claritas Rx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »